Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.0029
Abstract: This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis. read more here.
Keywords: safety upadacitinib; upadacitinib patients; efficacy safety; atopic dermatitis ... See more keywords
Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14112452
Abstract: Atopic dermatitis (AD) is a common skin condition characterized by inflammation that presents with erythematous and pruritic skin. Its chronic relapse-remitting nature has a significant impact on the quality of life, and often requires ongoing… read more here.
Keywords: atopic dermatitis; moderate severe; efficacy safety; safety upadacitinib ... See more keywords